Ski regulates hippo and TAZ signaling to suppress breast cancer progression

Science Signaling

Volumn 8, Issue 363, 2015, Pages

  Rashidian, Juliet ^a   Le Scolan, Erwan ^a   Ji, Xiaodan ^a   Zhu, Qingwei ^a   Mulvihill, Melinda M ^b   Nomura, Daniel ^b   Luo, Kunxin ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDES AND PROTEINS; PROTEIN HIPPO; PROTEIN LATS2; PROTEIN SKI; PROTEIN TAZ; PROTEIN YAP; TRANSFORMING PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HIPPO PROTEIN, HUMAN; LATS2 PROTEIN, HUMAN; LUCIFERASE; NUCLEAR PROTEIN; ONCOPROTEIN; PHOSPHOPROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SKI PROTEIN, HUMAN; SMALL INTERFERING RNA; TAZ PROTEIN, HUMAN; TEAD1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; STEM CELL EXPANSION; TUMOR XENOGRAFT; BREAST TUMOR; CELL TRANSFORMATION; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; IMMUNOPRECIPITATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UBIQUITINATION; WESTERN BLOTTING;

AVES;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENES, TUMOR SUPPRESSOR; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS; UBIQUITINATION;

EID: 84922694581     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2005735     Document Type: Article

References (60)

1. Y. Li, C. M. Turck, J. K. Teumer, E. Stavnezer, Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene. J. Virol. 57, 1065-1072 (1986).
2. J. A. Reed, E. Bales, W. Xu, N. A. Okan, D. Bandyopadhyay, E. E. Medrano, Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: Functional implications for transforming growth factor b signaling. Cancer Res. 61, 8074-8078 (2001).
3. M. Fukuchi,M.Nakajima, Y. Fukai,T.Miyazaki,N. Masuda, M. Sohda, R. Manda, K. Tsukada, H. Kato, H. Kuwano, Increased expression of c-Ski as a co-repressor in transforming growth factor-β signaling correlates with progression of esophageal squamous cell carcinoma. Int. J. Cancer 108, 818-824 (2004).
4. M. Buess, L. Terracciano, J. Reuter, P. Ballabeni, J. L. Boulay, U. Laffer, U. Metzger, R. Herrmann, C. Rochlitz, Amplification of SKI is a prognostic marker in early colorectal cancer. Neoplasia 6, 207-212 (2004).
5. T. R. Heider, S. Lyman, R. Schoonhoven, K. E. Behrns, Ski promotes tumor growth through abrogation of transforming growth factor-β signaling in pancreatic cancer. Ann. Surg. 246, 61-68 (2007).
6. M. Ritter, D. Kattmann, S. Teichler, O. Hartmann, M. K. Samuelsson, A. Burchert, J. P. Bach, T. D. Kim, B. Berwanger, C. Thiede, R. Jager, G. Ehninger, H. Schafer, N. Ueki,M. J. Hayman, M. Eilers, A. Neubauer, Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia. Leukemia 20, 437-443 (2006).
7. T. Shinagawa, T. Nomura, C. Colmenares, M. Ohira, A. Nakagawara, S. Ishii, Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice. Oncogene 20, 8100-8108 (2001).
8. D. Smedley, S. Sidhar, S. Birdsall, D. Bennett, M. Herlyn, C. Cooper, J. Shipley, Characterization of chromosome 1 abnormalities in malignant melanomas. Genes Chromosomes Cancer 28, 121-125 (2000).
9. -/- mice. Nat. Genet. 30, 106-109 (2002).
10. G. M. Brodeur, Neuroblastoma: Biological insights into a clinical enigma. Nat. Rev. Cancer 3, 203-216 (2003).
11. E. Le Scolan, Q. Zhu, L. Wang, A. Bandyopadhyay, D. Javelaud, A. Mauviel, L. Sun, K. Luo, Transforming growth factor-β suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. Cancer Res. 68, 3277-3285 (2008).
12. K. Luo, S. L. Stroschein, W. Wang, D. Chen, E. Martens, S. Zhou, Q. Zhou, The Ski oncoprotein interacts with the Smad proteins to repress TGFb signaling. Genes Dev. 13, 2196-2206 (1999).
13. S. Akiyoshi, H. Inoue, J. Hanai, K. Kusanagi, N. Nemoto, K. Miyazono, M. Kawabata, c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with smads. J. Biol. Chem. 274, 35269-35277 (1999).
14. J. W. Wu, A. R. Krawitz, J. Chai,W. Li, F. Zhang, K. Luo, Y. Shi, Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: Insights on Ski-mediated repression of TGF-β signaling. Cell 111, 357-367 (2002).
15. F. X. Yu, K. L. Guan, The Hippo pathway: Regulators and regulations. Genes Dev. 27, 355-371 (2013).
16. E. H. Chan, M. Nousiainen, R. B. Chalamalasetty, A. Schafer, E. A. Nigg, H. H. Sillje, The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24, 2076-2086 (2005).
17. M. Praskova, F. Xia, J. Avruch, MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr. Biol. 18, 311-321 (2008).
18. Y. Hao, A. Chun, K. Cheung, B. Rashidi, X. Yang, Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J. Biol. Chem. 283, 5496-5509 (2008).
19. J. Dong,G. Feldmann, J. Huang, S.Wu, N. Zhang, S. A. Comerford, M. F. Gayyed, R. A. Anders, A. Maitra, D. Pan, Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120-1133 (2007).
20. B.Zhao, X.Wei,W. Li, R.S. Udan, Q.Yang, J.Kim, J. Xie, T. Ikenoue, J. Yu, L. Li, P.Zheng, K. Ye, A. Chinnaiyan, G. Halder, Z. C. Lai, K. L. Guan, Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747-2761 (2007).
21. Q. Y. Lei, H. Zhang, B. Zhao, Z. Y. Zha, F. Bai, X. H. Pei, S. Zhao, Y. Xiong, K. L. Guan, TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol. Cell. Biol. 28, 2426-2436 (2008).
22. T. Oka, V. Mazack, M. Sudol, Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J. Biol. Chem. 283, 27534-27546 (2008).
23. Y. Fan, R. Mao, Y. Zhao, Y. Yu, W. Sun, P. Song, Z. Shi, D. Zhang, E. Yvon, H. Zhang, S. Fu, J. Yang, Tumor necrosis factor-α induces RelA degradation via ubiquitination at lysine 195 to prevent excessive nuclear factor-kB activation. J. Biol. Chem. 284, 29290-29297 (2009).
24. S. Wu, Y. Liu, Y. Zheng, J. Dong, D. Pan, The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev. Cell 14, 388-398 (2008).
25. M. Ota, H. Sasaki, Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 135, 4059-4069 (2008).
26. B. Zhao, J. Kim, X. Ye, Z. C. Lai, K. L. Guan, Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of Yesassociated protein. Cancer Res. 69, 1089-1098 (2009).
27. H. Zhang, C. Y. Liu, Z. Y. Zha, B. Zhao, J. Yao, S. Zhao, Y. Xiong, Q. Y. Lei, K. L. Guan, TEAD transcription factors mediate the function of TAZ in cell growth and epithelialmesenchymal transition. J. Biol. Chem. 284, 13355-13362 (2009).
28. I. Lian, J. Kim, H. Okazawa, J. Zhao, B. Zhao, J. Yu, A. Chinnaiyan, M. A. Israel, L. S. Goldstein, R. Abujarour, S. Ding, K. L. Guan, The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev. 24, 1106-1118 (2010).
29. M. Cordenonsi, F. Zanconato, L. Azzolin, M. Forcato, A. Rosato, C. Frasson, M. Inui, M. Montagner, A. R. Parenti, A. Poletti, M. G. Daidone, S. Dupont, G. Basso, S. Bicciato, S. Piccolo, The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147, 759-772 (2011).
30. K. Wang, C. Degerny, M. Xu, X. J. Yang, YAP, TAZ, and Yorkie: A conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochem. Cell Biol. 87, 77-91 (2009).
31. B. Zhao, X. Ye, J. Yu, L. Li, W. Li, S. Li, J. Yu, J. D. Lin, C. Y. Wang, A. M. Chinnaiyan, Z. C. Lai, K. L. Guan, TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962-1971 (2008).
32. C. Y. Liu, Z. Y. Zha, X. Zhou, H. Zhang, W. Huang, D. Zhao, T. Li, S. W. Chan, C. J. Lim, W. Hong, S. Zhao, Y. Xiong, Q. Y. Lei, K. L. Guan, The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCFb-TrCP E3 ligase. J. Biol. Chem. 285, 37159-37169 (2010).
33. H. W. Park, K. L. Guan, Regulation of the Hippo pathway and implications for anticancer drug development. Trends Pharmacol. Sci. 34, 581-589 (2013).
34. X. Varelas, R. Sakuma, P. Samavarchi-Tehrani, R. Peerani, B. M. Rao, J. Dembowy, M. B. Yaffe, P. W. Zandstra, J. L. Wrana, TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat. Cell Biol. 10, 837-848 (2008).
35. X. Varelas, P. Samavarchi-Tehrani, M. Narimatsu, A. Weiss, K. Cockburn, B. G. Larsen, J. Rossant, J. L. Wrana, The Crumbs complex couples cell density sensing to Hippodependent control of the TGF-β-SMAD pathway. Dev. Cell 19, 831-844 (2010).
36. Y. Sun, K. M. Yong, L. G. Villa-Diaz, X. Zhang, W. Chen, R. Philson, S. Weng, H. Xu, P. H. Krebsbach, J. Fu, Hippo/YAP-mediated rigidity-dependent motor neuron differentiation of human pluripotent stem cells. Nat. Mater. 13, 599-604 (2014).
37. H. Song, K. K. Mak, L. Topol, K. Yun, J. Hu, L. Garrett, Y. Chen, O. Park, J. Chang, R. M. Simpson, C. Y. Wang, B. Gao, J. Jiang, Y. Yang, Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc. Natl. Acad. Sci. U.S.A. 107, 1431-1436 (2010).
38. K. P. Lee, J. H. Lee, T. S. Kim, T. H. Kim, H. D. Park, J. S. Byun, M. C. Kim, W. I. Jeong, D. F. Calvisi, J. M. Kim, D. S. Lim, The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 107, 8248-8253 (2010).
39. A. I. McClatchey, I. Saotome, K. Mercer, D. Crowley, J. F. Gusella, R. T. Bronson, T. Jacks, Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev. 12, 1121-1133 (1998).
40. Z. C. Lai, X. Wei, T. Shimizu, E. Ramos, M. Rohrbaugh, N. Nikolaidis, L. L. Ho, Y. Li, Control of cell proliferation and apoptosis by Mob as tumor suppressor, mats. Cell 120, 675-685 (2005).
41. N. Tapon, K. F. Harvey, D. W. Bell, D.C. Wahrer, T. A. Schiripo, D. Haber, I. K. Hariharan, salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110, 467-478 (2002).
42. C. Seidel, U. Schagdarsurengin, K. Blumke, P.Wurl, G. P. Pfeifer, S. Hauptmann, H. Taubert, R. Dammann, Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma. Mol. Carcinog. 46, 865-871 (2007).
43. B. Zhao, L. Li, L. Wang, C. Y. Wang, J. Yu, K. L. Guan, Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 26, 54-68 (2012).
44. A. Jimenez-Velasco, J. Roman-Gomez, X. Agirre, M. Barrios, G. Navarro, I. Vazquez, F. Prosper, A. Torres, A. Heiniger, Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia. Leukemia 19, 2347-2350 (2005).
45. K. F. Harvey, X. Zhang, D. M. Thomas, The Hippo pathway and human cancer. Nat. Rev. Cancer 13, 246-257 (2013).
46. S. W. Chan, C. J. Lim, K. Guo, C. P. Ng, I. Lee, W. Hunziker, Q. Zeng, W. Hong, A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res. 68, 2592-2598 (2008).
47. A. Hergovich, B. A. Hemmings, Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling. Biofactors 35, 338-345 (2009).
48. D. Lai, K. C. Ho, Y. Hao, X. Yang, Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Res. 71, 2728-2738 (2011).
49. M. Overholtzer, J. Zhang, G. A. Smolen, B. Muir, W. Li, D. C. Sgroi, C. X. Deng, J. S. Brugge, D. A. Haber, Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl. Acad. Sci. U.S.A. 103, 12405-12410 (2006).
50. B. Zhao, K. Tumaneng, K. L. Guan, The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat. Cell Biol. 13, 877-883 (2011).
51. T. Nomura, M. M. Khan, S. C. Kaul, H. D. Dong, R. Wadhwa, C. Colmenares, I. Kohno, S. Ishii, Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev. 13, 412-423 (1999).
52. J. Deheuninck, K. Luo, Ski and SnoN, potent negative regulators of TGF-β signaling. Cell Res. 19, 47-57 (2009).
53. J. He, S. B. Tegen, A. R. Krawitz, G. S. Martin, K. Luo, The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins. J. Biol. Chem. 278, 30540-30547 (2003).
54. S. Lamouille, J. Xu, R. Derynck, Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178-196 (2014).
55. Q. Zhu, A. R. Krakowski, E. E. Dunham, L. Wang, A. Bandyopadhyay, R. Berdeaux, G. S. Martin, L. Sun, K. Luo, Dual role of SnoN in mammalian tumorigenesis. Mol. Cell. Biol. 27, 324-339 (2007).
56. L. Azzolin, F. Zanconato, S. Bresolin, M. Forcato, G. Basso, S. Bicciato, M. Cordenonsi, S. Piccolo, Role of TAZ as mediator of Wnt signaling. Cell 151, 1443-1456 (2012).
57. J. J. Adler, B. L. Heller, L. R. Bringman, W. P. Ranahan, R. R. Cocklin, M. G. Goebl, M. Oh, H. S. Lim, R. J. Ingham, C. D. Wells, Amot130 adapts atrophin-1 interacting protein 4 to inhibit Yes-associated protein signaling and cell growth. J. Biol. Chem. 288, 15181-15193 (2013).
58. N. S. Jahchan, D. Wang, M. J. Bissell, K. Luo, SnoN regulates mammary gland alveologenesis and onset of lactation by promoting prolactin/Stat5 signaling. Development 139, 3147-3156 (2012).
59. S. L. Stroschein, W. Wang, S. Zhou, Q. Zhou, K. Luo, Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science 286, 771-774 (1999).
60. X. Ji, H. Lu, Q. Zhou, K. Luo, LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis. eLife 3, e02907 (2014).